MAR-ATORVASTATIN

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: 51c9524e68cf8e81
Drug Approval Canada Name: MAR-ATORVASTATIN
Product Name: MAR-ATORVASTATIN
Status: Marketed
Status Date: 2017-05-12
Original Market Date: 2017-05-12
Din: 02454017
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:06.08
Atc Original: C10AA05 ATORVASTATIN
Atc Name: c 10 aa 05
Aig Number: 0133055001
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

ATORVASTATIN (ATORVASTATIN CALCIUM)

10 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

51c9524e68cf8e81

Type

Standard